FDA Receives Alcon, Inc. (ACL) Clearance To Implement Corrective Action Plan to Correct Malfunctions For Constellation Vision System  
12/6/2010 9:49:54 AM

Ortho Super Site -- HUENENBERG, Switzerland — The U.S. Food and Drug Administration has cleared Alcon's 510(k) submission to complete its voluntary medical device corrective action plan for its Constellation Vision System, the company announced in a press release.